Supha Pharmachem Limited (BOM:539561)
India
· Delayed Price · Currency is INR 0.410
-0.020 (-4.65%)
At close: Mar 9, 2026
Supha Pharmachem Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | 122.54 | 21.29 | 327.3 | 54.26 | 10.78 | 4.81 | Upgrade
|
| Depreciation & Amortization | 0.2 | 0.39 | 0.57 | 1.51 | 0.74 | 0.6 | Upgrade
|
| Other Operating Activities | 121.58 | 74.15 | 36.91 | 0.3 | 1.06 | 1.35 | Upgrade
|
| Change in Accounts Receivable | -6,094 | -7,716 | -7,478 | -1,084 | -403.12 | -221.85 | Upgrade
|
| Change in Inventory | -902.51 | -2,694 | -1,259 | 765.52 | -807.65 | -24.07 | Upgrade
|
| Change in Accounts Payable | 2,410 | 5,010 | 6,271 | -403.45 | 1,008 | 233.85 | Upgrade
|
| Change in Other Net Operating Assets | -5,642 | -6,044 | 1,360 | 870.64 | 303.11 | -96.82 | Upgrade
|
| Operating Cash Flow | -9,984 | -11,348 | -741.61 | 205 | 112.83 | -102.13 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | 81.69% | - | - | Upgrade
|
| Capital Expenditures | -58.24 | - | - | -0.43 | -0.5 | -0.39 | Upgrade
|
| Other Investing Activities | 0.96 | 1.29 | 0.94 | - | - | - | Upgrade
|
| Investing Cash Flow | -57.29 | 1.29 | 0.94 | -0.43 | -0.5 | -0.39 | Upgrade
|
| Short-Term Debt Issued | - | 11,414 | 577.03 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 101.37 | Upgrade
|
| Total Debt Issued | 10,176 | 11,414 | 577.03 | - | - | 101.37 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | -105.01 | - | Upgrade
|
| Net Debt Issued (Repaid) | 9,638 | 11,414 | 577.03 | - | -105.01 | 101.37 | Upgrade
|
| Other Financing Activities | -22.99 | -52.89 | -38.73 | -0.37 | -1.07 | - | Upgrade
|
| Financing Cash Flow | 10,094 | 11,361 | 538.29 | -0.37 | -106.08 | 101.37 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -75.23 | -0 | -0.94 | - | - | -0 | Upgrade
|
| Net Cash Flow | -22.74 | 14.27 | -203.32 | 204.2 | 6.25 | -1.14 | Upgrade
|
| Free Cash Flow | -10,042 | -11,348 | -741.61 | 204.57 | 112.33 | -102.51 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 82.12% | - | - | Upgrade
|
| Free Cash Flow Margin | -190.59% | -280.03% | -1.84% | 4.01% | 2.23% | -11.39% | Upgrade
|
| Free Cash Flow Per Share | -15.48 | -28.14 | -1.84 | 0.51 | 0.28 | -0.25 | Upgrade
|
| Cash Interest Paid | 2.71 | 2.71 | 38.73 | 0.37 | - | - | Upgrade
|
| Cash Income Tax Paid | 18.16 | - | 178.12 | 19.77 | 4.48 | 0.38 | Upgrade
|
| Levered Free Cash Flow | -9,657 | -10,856 | -922.25 | 190.6 | 110.69 | -103.49 | Upgrade
|
| Unlevered Free Cash Flow | -9,657 | -10,840 | -897.1 | 191.05 | 111.13 | -103.42 | Upgrade
|
| Change in Working Capital | -10,228 | -11,444 | -1,106 | 148.93 | 100.25 | -108.88 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.